Fibrinogen concentrate (FC) is concentrated fibrinogen derived from pooled human plasma which is available as a lyophilized powder requiring reconstitution before administration. Fibrinogen concentrates have a superior safety profile as a pathogen inactivated product, and logistical advantages with respect to dosing, storage and administration. There are two FC products currently available in Canada: RiaSTAP (CSL Behring) and Fibryga (Octapharma).

• Fibryga Reconstitution Guide – Canada
• Fibrinogen Concentrate Information Voice Over – Dr. Ryan Lett
• Reconstituting CSL Behring Canada Products using Mix2Vial

• Blood Bank Contact and Stock Information – Saskatchewan
• SHA Blood Products: Monographs & Resources – Fibryga
• SHA Blood Products: Monographs & Resources – RiaSTAP
• Fibryga: Human Fibrinogen Concentrate – fibrygaresources.ca
• Fibryga Virtual Tool Kit – Octapharma
• RiaSTAP: Administration Step-by-Step Guide – CSL Behring
• RiaSTAP: CSL Behring Healthcare Professional Hub
• RiaSTAP: Fibrinogen Concentrate (Human) Fact Sheet
• NAC Statement on Fibrinogen Concentrate Use in Acquired Hypofibrinogenemia
• Transfusion Best Practice Recommendations Saskatchewan